Selected article for: "cell reactivity and dataset validation"

Author: Asaf Poran; Dewi Harjanto; Matthew Malloy; Michael S. Rooney; Lakshmi Srinivasan; Richard B. Gaynor
Title: Sequence-based prediction of vaccine targets for inducing T cell responses to SARS-CoV-2 utilizing the bioinformatics predictor RECON
  • Document date: 2020_4_8
  • ID: 54mx8v4i_19
    Snippet: 2 Assays of T cell reactivity (e.g., interferon-gamma ELISpots, tetramers), which are stricter 3 measures for T cell immunogenicity to epitopes, were performed in significantly lower numbers 4 compared with MHC-binding assays. For HLA-I, the overlap between peptide-MHC allele pairs 5 for which we had a prediction (supported alleles) and pairs with a reported T cell assay consisted 6 of only 32 pairs, of which 23 had a positive result. We did not .....
    Document: 2 Assays of T cell reactivity (e.g., interferon-gamma ELISpots, tetramers), which are stricter 3 measures for T cell immunogenicity to epitopes, were performed in significantly lower numbers 4 compared with MHC-binding assays. For HLA-I, the overlap between peptide-MHC allele pairs 5 for which we had a prediction (supported alleles) and pairs with a reported T cell assay consisted 6 of only 32 pairs, of which 23 had a positive result. We did not detect differences in the percent 7 ranks across the positive and negative groups, however sample sizes are extremely small (data not 8 shown). In addition, for HLA-I epitopes, the validation dataset only contained T cell assay results 9 for peptide-MHC allele pairs that had a positive result in a binding assay, suggesting a biased pool 10 of epitopes selected for testing. Table 9 ). There were 259 unique peptide-MHC allele pairs assayed by MHC-binding assays in the 18 ViPR validation dataset for HLA-II. As before, we compared their percent rank with their reported 19 'best' (in the case of multiple measurements) MHC-binding assay result. This comparison could 20 not be performed with the "Negative" pairs as an independent group since there was only one 21 negative result in the validation dataset for HLA-II. The low negative counts may be due to under-22 reporting of negative assay results or biased selection of the peptides to be assayed. Therefore, we 23 author/funder. All rights reserved. No reuse allowed without permission.

    Search related documents:
    Co phrase search for related documents
    • allele pair and positive result: 1
    • allele support and assay result: 1
    • allele support and dataset validation: 1
    • allele support and negative assay result: 1
    • allele support and negative result: 1
    • allele support and peptide mhc: 1
    • allele support and percent rank: 1
    • allele support and positive result: 1
    • allele support and ViPR validation: 1
    • assay result and cell assay: 1, 2, 3, 4, 5, 6, 7
    • assay result and cell reactivity: 1
    • assay result and dataset validation: 1, 2, 3
    • assay result and interferon gamma: 1
    • assay result and negative assay result: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • assay result and negative assay result reporting: 1
    • assay result and negative result: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • assay result and peptide mhc: 1, 2, 3, 4
    • assay result and percent rank: 1, 2, 3
    • assay result and positive result: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46